Bengaluru: Biocon Biologics Limited is now a step closer to launching its Aflibercept biosimilar, after gaining approval from the US…
Trending
- 919% Growth, Rs 4,500 Crore Market: Why StudioBackdrops Is Betting on Infrastructure
- Snapchat Adds AI Tools That Turn Chats Into Songs
- ‘Not Even a Tiny Bit’: Iran Tells Asim Munir Enriched Uranium Won’t Leave the Country
- Spotify Pulls Over 50 Million AI ‘Slop’ Tracks From Recommendations
- From Flight Delays to Lost Baggage: HDFC ERGO Highlights the Wider Role of Travel Insurance
- Reliance’s Jamnagar Refinery Could Gain From Venezuelan Oil. Here’s What Experts have to say
- Elon Musk Sees SpaceX Reaching $1 Trillion Revenue. Here’s His Timeline
- Microsoft says 80% of H-1B visa applications were for existing employees after US green card suspension
